FDA To Alter Rules On Medical Devices; Companies Such as Cytori Therapeutics, Inc. Faces Higher Hurdles

Boston Globe -- WOBURN — Fielding complaints about poor communication and delays in reviewing and approving new products, the top US medical device regulator yesterday said his agency will overhaul its procedures to speed innovation while protecting patient safety.